Baker and McKenzie advised the listed STRATEC Biomedical AG, Birkenfeld, on its purchase of hematology systems specialist Diatron. The contract for the complete acquisition of Diatron MI PLC, Budapest, Hungary, its American sister company and the overlying holding structure by the STRATEC Biomedical AG was completed on 31 March 2016.

Seller was the private equity firm The Riverside Company, headquartered in New York and Cleveland. Diatron develops and manufactures system solutions in the field of hematology and related consumables.

Baker & McKenzie advised STRATEC on all legal aspects of the purchase. Both parties have agreed not to disclose the purchase price.

Diatron was founded over 25 years ago and provides analysis systems and complementary products, such as consumables and services, for human and veterinary diagnostics for well-known global life science companies in more than 100 countries. In the past fiscal year, the company generated sales of around € 34 million with a comparable profitability  of the STRATEC Group. About 200 employees are located in Hungary and the United States and are primarily involved in the development, manufacturing and sales

The Corporate / M&A team of Baker & McKenzie regularly advises on cross-border transactions and restructuring. Most recently , e.g., Baker & McKenzie provided advice to RWE and E.ON on the sale of its minority holdings in Luxembourg energy provider Enovos, the Deutsche Beteiligungs AG on its acquisition of a substantial minority interest in mageba AG, HITACHI KOKI on its acquisition of the power tool specialist Metabo AG, Barry-Wehmiller Group on the acquisition of Winkler+Dünnebier GmbH, ZF Friedrichshafen AG on the acquisition of the industrial and wind turbine business of Bosch Rexroth AG, Group Le Duff on the acquisition of Kamps, Telefónica/E-Plus on the sale of yourfone to Drillisch, Flowserve Corporation on the acquisition of the SIHI Group, and Hochtief on the sale of the property management business to vincitag and the offshore business to GeoSea.

Legal adviser to STRATEC Biomedical AG:                  

Baker & McKenzie

Lead: Corporate/M&A: Pal Takacs (partner, Budapest), Gerald Schumann (partner, München), Dr. Jon Marcus Meese (partner, München)

Team:

Corporate/M&A: Erzebet Szalay (associate, Budapest), Torsten Schmitt (partner, Luxembourg), Nawal Sabsibo (associate, Luxemburg)

IP: Dr. Benjamin Koch (partner, München

Tax: Dr. Dr. Norbert Mückl (partner, München)

as well as further lawyers in Hungary, Luxembourg and the USA.